|
TCIRG1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.104300E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.138000E-03 |
| Normal-vs-Stage2 |
1.998040E-02 |
| Normal-vs-Stage3 |
6.360300E-02 |
| Normal-vs-Stage4 |
1.116450E-01 |
| Stage1-vs-Stage2 |
7.956200E-01 |
| Stage1-vs-Stage3 |
9.962800E-01 |
| Stage1-vs-Stage4 |
4.188000E-01 |
| Stage2-vs-Stage3 |
8.532400E-01 |
| Stage2-vs-Stage4 |
5.604200E-01 |
| Stage3-vs-Stage4 |
4.368200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.695400E-03 |
| Normal-vs-AfricanAmerican |
2.807600E-02 |
| Normal-vs-Asian |
8.433600E-02 |
| Caucasian-vs-AfricanAmerican |
7.960400E-01 |
| Caucasian-vs-Asian |
1.238000E-01 |
| AfricanAmerican-vs-Asian |
1.204980E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.558800E-03 |
| Normal-vs-Female |
6.910200E-02 |
| Male-vs-Female |
2.469200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.789560E-02 |
| Normal-vs-Extreme_Weight |
6.438300E-03 |
| Normal-vs-Obese |
4.655900E-02 |
| Normal-vs-Extreme_Obese |
8.107000E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.528600E-01 |
| Normal_Weight-vs-Obese |
3.441400E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.567800E-02 |
| Extreme_Weight-vs-Obese |
4.778200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.526100E-02 |
| Obese-vs-Extreme_Obese |
3.365600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.475620E-02 |
| Normal-vs-Age(41-60Yrs) |
1.402090E-02 |
| Normal-vs-Age(61-80Yrs) |
3.621300E-03 |
| Normal-vs-Age(81-100Yrs) |
5.088600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.080010E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.030400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.252400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.300200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.336800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.364600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.108000E-02 |
| Normal-VS-Type2 PRCC |
1.171050E-01 |
| Normal-VS-KIRP CIMP |
3.185700E-02 |
| Normal-VS-Unclassified PRCC |
9.031100E-04 |
| Type1 PRCC-VS-Type2 PRCC |
7.382200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.380040E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.678300E-02 |
| Type2 PRCC-VS-KIRP CIMP |
9.792400E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
3.049700E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
7.735400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.962200E-02 |
| Normal-vs-N1 |
4.819600E-03 |
| Normal-vs-N2 |
8.170500E-02 |
| N0-vs-N1 |
2.307800E-01 |
| N0-vs-N2 |
7.619800E-01 |
| N1-vs-N2 |
7.767800E-01 |
|
|
